SV2011003785A - Nuevas posibilidades de lucha contra la giardiasis - Google Patents

Nuevas posibilidades de lucha contra la giardiasis

Info

Publication number
SV2011003785A
SV2011003785A SV2011003785A SV2011003785A SV2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A SV 2011003785 A SV2011003785 A SV 2011003785A
Authority
SV
El Salvador
Prior art keywords
fight against
new possibilities
giardiasis
against giardiasis
possibilities
Prior art date
Application number
SV2011003785A
Other languages
English (en)
Inventor
Gisela Greif
Achim Harder
Thomas Bach
Gabriele Petry
Eva-Maria Kruedewagen
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SV2011003785A publication Critical patent/SV2011003785A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

LA PRESENTE INVENCIÓN SE REFIERE AL USO DE NIFURTIMOX PARA EL TRATAMIENTO DE GIARDIASIS, EN PARTICULAR EN PERROS Y GATOS
SV2011003785A 2008-07-02 2011-01-03 Nuevas posibilidades de lucha contra la giardiasis SV2011003785A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008031284A DE102008031284A1 (de) 2008-07-02 2008-07-02 Neue Bekämpfungsmöglichkeit der Giardiose

Publications (1)

Publication Number Publication Date
SV2011003785A true SV2011003785A (es) 2011-05-20

Family

ID=41077987

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2011003785A SV2011003785A (es) 2008-07-02 2011-01-03 Nuevas posibilidades de lucha contra la giardiasis

Country Status (30)

Country Link
US (1) US8440612B2 (es)
EP (1) EP2310018B1 (es)
JP (1) JP5627579B2 (es)
KR (1) KR101720805B1 (es)
CN (1) CN102083441B (es)
AR (1) AR072425A1 (es)
AU (1) AU2009266125B2 (es)
BR (1) BRPI0913889B1 (es)
CA (1) CA2729730C (es)
CL (2) CL2010001577A1 (es)
CO (1) CO6321270A2 (es)
CR (1) CR20110022A (es)
DE (1) DE102008031284A1 (es)
DK (1) DK2310018T3 (es)
DO (1) DOP2010000405A (es)
EC (1) ECSP10010720A (es)
ES (1) ES2444581T3 (es)
HK (1) HK1158113A1 (es)
IL (1) IL209698A (es)
MX (1) MX2010014446A (es)
MY (1) MY157007A (es)
NI (1) NI201100008A (es)
NZ (1) NZ590276A (es)
PE (1) PE20110283A1 (es)
PL (1) PL2310018T3 (es)
RU (1) RU2538713C9 (es)
SV (1) SV2011003785A (es)
UA (1) UA103328C2 (es)
WO (1) WO2010000399A1 (es)
ZA (1) ZA201009225B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814694C (en) * 2010-10-12 2019-01-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis
SG10202103403SA (en) 2015-05-20 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
CN108699052B (zh) 2015-12-28 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3750527A1 (en) * 2019-06-13 2020-12-16 Bayer AG Stable tablet formulation of nifurtimox and process for producing the same
CN114377018B (zh) * 2020-10-21 2024-02-06 中国医学科学院药物研究所 硝呋莫司在制备抗流感病毒药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170957B (de) * 1962-11-23 1964-05-27 Bayer Ag Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
JPH081908B2 (ja) * 1987-07-22 1996-01-10 三菱電機株式会社 超格子半導体素子
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
ATE211466T1 (de) 1992-03-17 2002-01-15 Fujisawa Pharmaceutical Co Depsipeptide, herstellung und anwendung
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
AU695021B2 (en) 1993-02-19 1998-08-06 Meiji Seika Kaisha Ltd. PF1022 derivative cyclic depsipeptide
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
CA2171088A1 (en) 1993-09-06 1995-03-16 Hitoshi Nishiyama Cyclodepsipeptide compound
DE4401389A1 (de) 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
RU2074038C1 (ru) * 1994-06-16 1997-02-27 Товарищество с ограниченной ответственностью Предприятие "ТЕПАРК" Способ изготовления полых металлических емкостей
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
ATE425973T1 (de) 1995-06-30 2009-04-15 Astellas Pharma Inc Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
CZ295705B6 (cs) 1995-09-22 2005-10-12 Bayer Aktiengesellschaft Cyklodepsipeptidové deriváty sloučeniny PF1022 a farmaceutický prostředek s jejich obsahem
DE19545639A1 (de) 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5874630A (en) * 1998-01-06 1999-02-23 Occidental Chemical Corporation Synthesis of mercaptans from alcohols
US6133228A (en) * 1998-05-28 2000-10-17 Firmenich Sa Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters
DE19828047A1 (de) * 1998-06-24 1999-12-30 Bayer Ag Substituierte Cyclooctadepsipeptide
CA2586950A1 (en) * 2004-11-12 2006-05-18 Celgene Corporation Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases
DE102005033496A1 (de) 2005-07-19 2007-01-25 Bayer Healthcare Ag Desinfektionsmittel

Also Published As

Publication number Publication date
ECSP10010720A (es) 2011-01-31
CA2729730A1 (en) 2010-01-07
RU2538713C9 (ru) 2015-08-20
PL2310018T3 (pl) 2014-05-30
CA2729730C (en) 2016-03-22
RU2011103475A (ru) 2012-08-10
CL2010001577A1 (es) 2011-05-06
NZ590276A (en) 2012-12-21
MY157007A (en) 2016-04-15
AR072425A1 (es) 2010-08-25
ES2444581T3 (es) 2014-02-25
AU2009266125A1 (en) 2010-01-07
EP2310018B1 (de) 2013-12-18
JP5627579B2 (ja) 2014-11-19
DOP2010000405A (es) 2011-01-15
CO6321270A2 (es) 2011-09-20
DE102008031284A1 (de) 2010-01-07
RU2538713C2 (ru) 2015-01-10
WO2010000399A1 (de) 2010-01-07
US8440612B2 (en) 2013-05-14
CN102083441A (zh) 2011-06-01
CN102083441B (zh) 2013-07-24
US20110105388A1 (en) 2011-05-05
MX2010014446A (es) 2011-02-22
PE20110283A1 (es) 2011-05-07
HK1158113A1 (en) 2012-07-13
IL209698A0 (en) 2011-02-28
IL209698A (en) 2016-03-31
CL2013000709A1 (es) 2013-08-23
DK2310018T3 (da) 2014-03-24
KR20110031357A (ko) 2011-03-25
AU2009266125B2 (en) 2015-06-04
KR101720805B1 (ko) 2017-03-28
UA103328C2 (uk) 2013-10-10
NI201100008A (es) 2011-08-10
ZA201009225B (en) 2012-03-28
BRPI0913889A2 (pt) 2015-10-27
JP2011526265A (ja) 2011-10-06
BRPI0913889B1 (pt) 2019-02-05
EP2310018A1 (de) 2011-04-20
CR20110022A (es) 2011-05-10

Similar Documents

Publication Publication Date Title
SV2009003098A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
CO6731068A2 (es) Arilpirrolodonas pesticidas
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BRPI0924425A2 (pt) "combinações de substâncias ativas sinergéticas".
BRPI1011655A2 (pt) uso de lcat para tratar anemia e disfunção de glóbulos vermelhos
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
CL2008002893A1 (es) Compuestos derivados de n-fenil-(piridin-3-il) acetamida sustituidas; composicion farmaceutica; procedimiento de preparacion; y su uso para prevenir o tratar el cancer.
CL2009001484A1 (es) Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BR112012028719A2 (pt) composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação
BRPI0911031B8 (pt) compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
CL2011002548A1 (es) Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica.
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
BR112012001080A2 (pt) Combinações de substâncias ativas sinérgicas contendo feniltriazóis
SV2011003785A (es) Nuevas posibilidades de lucha contra la giardiasis
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
BRPI0910359A2 (pt) método para inibir o crescimento de microorganismos e composição biocida
EP2300599A4 (en) INCREASING THE EFFECTIVENESS OF CELL THERAPY, INCLUDING TREATMENT WITH ALPHA-1-3-FUCOSYLTRANSFERASE
GT201400050A (es) Derivados de anilina, su preparación y su aplicación terapéutica
ES2399651T8 (es) Utilización de pasireotida para el tratamiento de la hipoglucemia hiperinsulenémica endógena
BR112014009456A2 (pt) uso de melatonina para o tratamento e/ou prevenção de mucosite
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce

Legal Events

Date Code Title Description
FG Grant
FG Grant